| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 10/07/2010 | US20100254966 Treatment of glycogen storage disease type ii |
| 10/07/2010 | CA2757188A1 Pyrimidine compound |
| 10/06/2010 | EP2236156A2 Methods for treating and diagnosing Psoriasis |
| 10/06/2010 | EP2236152A1 Albumin fusion proteins |
| 10/06/2010 | EP2234625A2 Compositions and methods for treating and preventing skeletal muscle deficiencies |
| 10/06/2010 | EP2234622A2 Methods for enhancing muscle performance and tone |
| 10/06/2010 | EP1296951B1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3'] bipyridinyl in pure crystalline form and process for synthesis |
| 10/06/2010 | EP1220906B1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 10/06/2010 | CN1864667B A stable lyophilized preparation of rocuronium bromide and preparation method thereof |
| 10/06/2010 | CN1681508B Novel inhibitors of kinases |
| 10/06/2010 | CN101854979A C-19 steroids for therapeutic uses |
| 10/06/2010 | CN101851220A Isoprene flavonoid compound and application thereof |
| 10/05/2010 | US7807659 5-Fluoro-4-oxo-3-[1-(substituted-carbonyl)-2-piperidinecarboxamido]-pentanoic acid derivatives such as [3S/R (2S)]-5-Fluoro-4-oxo-3-[1-(2-phenyl-thiazole-4-carbonyl)-2-piperidinecarboxamido]-pentanoic acid, used for the treatment of bone disorders, inflammatory, autoimmune and degenerative diseases |
| 10/05/2010 | US7807655 uridine-5'-monophosphate or cytidine-5'-monophosphate for the treatment of affections of the peripheral nervous system, particularly polyneuropathies, neuritides, and myopathies; for stimulating the regeneration of nerves |
| 10/05/2010 | US7807654 Compositions and methods for treatment of mitochondrial diseases |
| 10/05/2010 | US7807170 Modulating an immune response in a subject by administering an effective amount of a lymphocyte differentiation factor; antiinflammatory agents |
| 09/30/2010 | WO2010110440A1 Novel therapeutic agent for cognitive impairment |
| 09/30/2010 | WO2010109386A1 Method for the industrial purification of biologically active phycotoxins |
| 09/30/2010 | WO2010108843A1 Use of nitrooxyderivative of paracetamol for the treatment of muscular dystrophies |
| 09/30/2010 | US20100249241 N,n-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same |
| 09/30/2010 | US20100249218 Method to inhibit cell growth using oligonucleotides |
| 09/30/2010 | US20100249189 Nitric oxide donor compounds |
| 09/30/2010 | US20100249150 Stable pharmaceutical composition of freeze-dried tetrodoxin powder |
| 09/30/2010 | US20100249032 Human EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses |
| 09/30/2010 | US20100247678 Use of carbon dioxide supplying means for muscle strengthening and method of increasing cattle meat thereby |
| 09/30/2010 | US20100247495 Treatment of Muscular Dystrophy |
| 09/30/2010 | CA2754416A1 Novel medicament for treating cognitive impairment |
| 09/30/2010 | CA2754154A1 Method for the industrial purification of biologically active phycotoxins |
| 09/29/2010 | EP2233483A1 Indole or Benzimidazole derivatives as IkB-kinase modulators and intermediates in their preparation. |
| 09/29/2010 | EP2233141A1 Ppharmaceutical compositions coprising polymorphic forms of dehydroepiandrosterone |
| 09/29/2010 | EP2231588A1 Organic salts of -alanine |
| 09/29/2010 | CN201591849U Tizanidine hydrochloride scratch tablet |
| 09/29/2010 | CN1475207B Solid oral dosage mode containing walshaden and hydrochloric thizaine |
| 09/29/2010 | CN101848918A Mitochondrial compositions and uses thereof |
| 09/29/2010 | CN101843801A Bone permeable blood-activating and pain-relieving tincture |
| 09/29/2010 | CN101843653A Processing method of Chinese stellera root condensed decoction |
| 09/29/2010 | CN101843593A Novel vecuronium bromide freeze-dried preparation and preparation method thereof |
| 09/29/2010 | CN101054414B Method of extracting and preparing deer DGF |
| 09/28/2010 | US7803923 Growth differentiation factor-8 binding agents for treatment of metabolic, nervous system, muscular, bone , urogenital and inflammatory disorders; for treating muscle-wasting disorders and metabolic disorders including diabetes and obesity |
| 09/28/2010 | US7803749 Prevent signal transduction passageways; kinase inhibitor; modulate immunology response |
| 09/28/2010 | CA2383524C Thiazolyl alkynyl compounds and methods of use thereof |
| 09/23/2010 | WO2010108001A2 Agents and methods for tissue repair and regeneration |
| 09/23/2010 | WO2010106295A1 Use of decorin for increasing muscle mass |
| 09/23/2010 | US20100240724 Edible Film |
| 09/23/2010 | US20100239654 Vesicular phospholipid gels comprising proteinaceous substances |
| 09/23/2010 | US20100239534 Hybrid proteins that migrate retrogradely and transynaptically into the CNS |
| 09/23/2010 | US20100239530 Ifnar2 mutants, their production and use |
| 09/23/2010 | CA2755509A1 Agents and methods for tissue repair and regeneration |
| 09/22/2010 | CN1893961B Biologically active blood serum obtained by electroshock |
| 09/22/2010 | CN101837080A Oolong spur eliminating paste |
| 09/22/2010 | CN101837024A Quick-acting medicament for curing tic disorder disease |
| 09/21/2010 | US7799832 Especially tolperisone or its analogs eperisone or silperisone, or riluzole, propafenone, lidocaine, flecainide or metixen or their salts; treating pains which are accompanied by an increase in muscle tone |
| 09/21/2010 | US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis |
| 09/21/2010 | US7799786 Therapeutic agents useful for treating pain |
| 09/21/2010 | US7799775 Pyrimidine derivatives |
| 09/21/2010 | US7799763 Muscle-strengthening drugs and anti-inflammatory drugs |
| 09/21/2010 | CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them |
| 09/21/2010 | CA2211578C Muscle protein proteolysis inhibiting agent containing il-6 receptor antibody |
| 09/16/2010 | WO2010104024A1 Piperazine compound capable of inhibiting prostaglandin d synthase |
| 09/16/2010 | WO2010052563A3 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof |
| 09/16/2010 | US20100234402 Methods and compositions for treating spinal muscular atrophy |
| 09/16/2010 | US20100233722 Methods for determining the biological effect and/or activity of r pharmaceutical compositions based on their effect on the methylation status of the DNA |
| 09/16/2010 | US20100233294 Use of tellurium compounds for inhibition of interleukin-converting enzyme |
| 09/16/2010 | US20100233233 Tenocyte containing bioscaffolds and treatment using the same |
| 09/16/2010 | US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides |
| 09/16/2010 | US20100233143 Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells |
| 09/16/2010 | CA2754613A1 Piperazine compound capable of inhibiting prostaglandin d synthase |
| 09/16/2010 | CA2748856A1 Riluzole aqueous suspensions |
| 09/15/2010 | EP2227245A2 Combination of protein tyrosine phosphatase inhibitors and human growth hormone for the treatment of muscle atrophy and related disorders |
| 09/15/2010 | EP1611144B1 Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists |
| 09/15/2010 | CN101830889A 嘧啶衍生物 Pyrimidine derivatives |
| 09/15/2010 | CN101829291A Traditional Chinese medicine preparation for treating rheumatism and preparation method thereof |
| 09/15/2010 | CN101829245A Compound agilawood essential oil |
| 09/15/2010 | CN101828771A Calcium carbide liquid health-care clothes |
| 09/14/2010 | US7795018 expresses CD14, CD34, CD45, type I collagen, and HLA-DR; differentiates into osteoblasts, skeletal myoblasts or chondrocytes; obtained by culturing peripheral blood mononuclear cells (PBMCs) in vitro on fibronectin; noninvasive; will not cause rejection at the time of cell transplantation |
| 09/14/2010 | US7794744 Nutritional modules |
| 09/14/2010 | CA2343569C Mammalian transforming growth factor beta - 9 |
| 09/09/2010 | US20100228018 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 09/09/2010 | US20100227814 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes |
| 09/09/2010 | US20100226968 Topical agent for muscle treatment |
| 09/09/2010 | US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides |
| 09/09/2010 | US20100226891 Surface expression vector for fusion protein of myo-2 peptide multimer and myostatin, and microorganism transformed by thereof |
| 09/08/2010 | EP1478624B1 Chemical compounds |
| 09/08/2010 | EP1412374B1 Novel pgc-1 isoforms and uses therefor |
| 09/08/2010 | CN1659144B Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 09/08/2010 | CN101823964A Technology for preparing chlorogenic acid in viburnum sargentii koehne leaves |
| 09/08/2010 | CN101822784A Plaster for treating spur and preparation method thereof |
| 09/08/2010 | CN101822732A Traditional Chinese medicinal preparation for treating pain and numbness of limbs |
| 09/08/2010 | CN101014329B Pharmaceutical composition for preventing or treating rejection reaction of organ or tissue transplant, host resistance reaction of implant in bone marrow transplantation |
| 09/07/2010 | US7790916 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine |
| 09/07/2010 | US7790723 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes |
| 09/07/2010 | US7790698 2-Alkoxyadeosine or 2-alkoxy-3'-deoxyadenosine where the alkoxy contains 1-4 carbon atoms; particularly 2-methoxy-adenosine (spongosine) or salt; antiinflammatory agents; side effect reduction, particularly, cardiovascular disorders such as bradycardia and tachycardia |
| 09/07/2010 | US7790692 Improving tissue survival; methods for enhancing organ transplant, musculocutaneous flap or skin graft survival by administering a nucleic acid sequence encoding hepatocyte growth factor; neovascularization; surgery; tissue-targeted therapy |
| 09/07/2010 | US7790165 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases |
| 09/07/2010 | US7790158 Using tumor necrosis factors specific immunoglobulins to treat rheumatoid arthritis, diabetes type I, multiple sclerosis, and inflammatory bowel diseases |
| 09/07/2010 | CA2492081C Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 09/07/2010 | CA2414774C Use of dopamine d2/d3 receptor agonists to treat fibromyalgia |
| 09/02/2010 | US20100222576 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 09/02/2010 | US20100222419 Method to inhibit cell growth using oligonucleotides |
| 09/02/2010 | US20100222348 Quinolinone derivatives as parp inhibitors |